Resumen

NENINGER VINAGERAS, Elia et al. Descriptive study of response to chemotherapy in patients with inoperable non-small cell lung carcinoma. Rev cubana med [online]. 2008, vol.47, n.1, pp. 0-0. ISSN 1561-302X.

The results of a descriptive and retrospective study based on the therapeutic standardization of the patients with inoperable non-small cell lung cancer that received cisplatin-vinblastine combined chemotherapy were reported to determine their survival. It was observed that 185 were administered endovenous treatment (cisplatin 100 mg/m2 and vinblastine 6 mg/m2) the first day and, later, every 21 days; 125 (78 %) received between 4 and 6 treatment cycles. It was found that the global survival of all the patients was 11.82 months (mean 8.43), whereas in the stages IIIB and IV it was 9.11 (mean 7.60) and 8.96 months (mean 5.80), respectively. In these stages, it was obtained 48 % of control of the disease considered as an objective response plus stabilization. Toxicity was mainly digestive, renal and haematological. A trend towards survival was observed among females. No differences were detected in the survival between the stages IIIB and IV. However, in those patients among whom a control of the disease was attained, the survival was significantly higher. It was concluded that the patients in stages IIIB and IV with a good general condition had a greater survival, as well as those that presented only one comorbidity.

Palabras clave : Non-small cell carcinoma; cisplatin; chemotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )